Ju-ju Shang
Beijing, 100010, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Shen Yuan Yi Qi Huo Xue capsules inhibit neutrophil NETosis by regulating the PAD4/NLRP3 signaling pathway to prevent heart failure after myocardial infarction.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 08, 2025
Effect of Kuanxiong Aerosol on Perioperative Coronary Microcirculation in Patients with Unstable Angina Undergoing Elective PCI: A Pilot Randomized Controlled Trial.
Journal: Chinese journal of integrative medicine
Published: August 12, 2024
Pharmacological Effects of Botanical Drugs on Myocardial Metabolism in Chronic Heart Failure.
Journal: Chinese journal of integrative medicine
Published: July 24, 2023
Danhong Injection Up-regulates miR-125b in Endothelial Exosomes and Attenuates Apoptosis in Post-Infarction Myocardium.
Journal: Chinese journal of integrative medicine
Published: June 19, 2023
Characterization of mild or asymptomatic patient admitted with Omicron variant of COVID-19 infection in Tibetan mobile cabin hospital China, August-October 2022.
Journal: Frontiers in public health
Published: February 27, 2023
A randomized, placebo-controlled, double-blind trial to evaluate efficacy and safety of Shen-Yuan-Dan capsules, a traditional Chinese medicine, for treatment of peri-procedure myocardial injury following percutaneous coronary intervention.
Journal: Complementary therapies in medicine
Published: August 09, 2021
Clinical Characteristics and Risk Factors of Periprocedural Myocardial Injury in Patients with Elective PCI in a TCM Hospital.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 07, 2021
Acute Myocardial Infarction in Chinese Medicine Hospitals in China from 2006 to 2013: An Analysis of 2311 Patients from Hospital Data.
Journal: Chinese journal of integrative medicine
Published: October 18, 2019
Danhong injection enhances angiogenesis after myocardial infarction by activating MiR-126/ERK/VEGF pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 25, 2019
Efficacy and safety of Shen-Yuan-Dan capsules for peri-procedural myocardial injury following percutaneous coronary intervention: study protocol for a randomized, double-blind, placebo-controlled trial.
Journal: Annals of translational medicine
Published: April 30, 2019
Recurrent coronary restenosis treated with Chinese medicine: A case report.
Journal: Chinese journal of integrative medicine
Published: April 23, 2016
Last Updated: 09/26/2026